1333114-52-5

Basic information

• Product Name: tert-butyl (1-(4-bromophenyl)-3-hydroxypropan-2-yl)carbamate
• Synonyms: tert-butyl (1-(4-bromophenyl)-3-hydroxypropan-2-yl)carbamate
• CAS NO: 1333114-52-5
• Molecular Weight: 330.222
• Mol File: 1333114-52-5.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl (1-(4-bromophenyl)-3-hydroxypropan-2-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (1-(4-bromophenyl)-3-hydroxypropan-2-yl)carbamate(1333114-52-5)
• EPA Substance Registry System: tert-butyl (1-(4-bromophenyl)-3-hydroxypropan-2-yl)carbamate(1333114-52-5)

Safety Data

• Hazardous Substances Data: 1333114-52-5(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 86886-33-1 2-amino-3-(4-bromophenyl)propanol 
• 166967-59-5 ethyl 2-amino-3-(4-bromophenyl) propanoate 
• 132067-41-5 methyl (±)-3-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate 

Downstream Products

• 1333114-53-6 methyl 2-((3-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)propoxy)methyl)-benzoate 
• 1431556-76-1 C₁₄H₁₈BrNO₃ 
• 1333114-58-1 4-(4-bromobenzyl)-3,4,5,6-tetrahydro-1H-benzo[f][1,4]oxazocine 
• 1333114-59-2 4-(4-bromobenzyl)-5-((2-methoxyphenyl)sulfonyl)-3,4,5,6-tetrahvdro-1H-benzo-[f][1,4]oxazocine 
• 1333114-57-0 1-((2-(bromomethyl)benzyl)oxy)-3-(4-bromophenyl)propan-2-amine trifluoroacetate 
• 1333114-55-8 tert-butyl (1-((2-(bromomethyl)benzyl)oxy)-3-(4-bromophenyl)propan-2-yl)carbamate 
• 1333114-54-7 tert-butyl (1-(4-bromophenyl)-3-((2-(hydroxymethyl)benzyl)oxy)propan-2-yl)carbamate 

Relevant articles and documents

SUBSTITUTED BIARYL ALKYL AMIDES

Disclosed herein are substituted biaryl alkyl amide compounds, methods of synthesizing substituted biaryl alkyl amide compounds and methods of treating diseases and/or conditions with substituted biaryl alkyl amide compounds.

NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE

The invention provides modulators for the orphan nuclear receptor RORγ and methods for treating RORγ mediated diseases by administrating these novel RORγ modulators to a human or a mammal in need thereof. Specifically, the present invention provides compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.

Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease

The invention provides modulators for the orphan nuclear receptor RORγ and methods for treating RORγ mediated diseases by administrating these novel RORγ modulators to a human or a mammal in need thereof. Specifically, the present invention provides compounds of formula (1) or (2) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.